Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (GATD3B) is a predicted mitochondrial protein encoded by the GATD3B gene (Ensembl: ENSG00000280071), located on human chromosome 21. It belongs to the putative glutamine amidotransferase-like class 1 domain-containing protein family, showing paralogy with GATD3 (which has been studied in the context of Down syndrome), but the biological function, enzymatic activity, and disease roles of GATD3B itself remain largely uncharacterized. There is minimal evidence for its role as a therapeutic target, no established drug interactions, mechanisms of action, or biomarker roles, and no specific safety concerns are reported in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (GATD3B).